LM

Lukas Möller

BioEng PhD candidate @Caltech | Elowitz lab | prev. @MIT, @Broadinstitute, @ETH

Pasadena, California

Invests in

Stages:

  • Min Investment:

    $250,000.00
  • Max Investment:

    $750,000.00
  • Target Investment:

    $500,000.00

Work Experience

2023

  • PHD Student

    2023

    Graduate research in Michael Elowitz's lab (SynBio): development of therapeutic protein circuits

  • Visiting Master's Student

    2022 - 2023

    Lab of Professor Feng Zhang: supporting team effort to discover, characterize, and engineer novel bacterial effector systems

  • Visiting Master's Student

    2022 - 2023

    Research in the lab of Professor Feng Zhang

2021 - 2022

  • Master's Student Researcher

    2021 - 2022

    Lab of Professor Jacob Corn: Development of Recursive Editing Recursive Editing is a method to drive high levels of HDR-repair outcomes and reduce undesired edits in CRISPR gene editing applications without cell state manipulation. Recursive Editing is based on the repeated retargeting of undesired editing byproducts. We also provide the web-tool REtarget for the automated design of Recursive Editing reagents. Our work is featured in Nature Communications: Möller, L., Aird, E. J., Schröder, M. S., Kobel, L., Kissling, L., van de Venn, L., Corn, J. E. Recursive Editing improves homology-directed repair through retargeting of undesired outcomes. Nat. Commun. 13, 4550 (2022)

  • Master's Student Researcher

    2021 - 2022

    Lab of Professor Gisbert Schneider: Machine learning-guided RNA Ligand Binding Site Prediction We developed the 3D-CNN deep-learning model RNet to predict RNA ligand binding sites. We demonstrate that protein-based pre-training improves prediction performance and helps to escape small data-regime limitations. Our work is featured in Molecular Informatics: Möller, L., Guerci, L., Isert, C., Atz, A., Schneider, G. Translating from Proteins to Ribonucleic Acids for Ligand-binding Site Detection. Mol. Inf. 41, 10 (2022)

2021 - 2021

  • Investment Intern

    2021 - 2021

    Global early-stage technology investment firm, venture capital (VC) Focus of my work: supporting early-stage biotech & AI-driven healthcare investments, biotech market analysis

2020 - 2020

  • Master's Student Researcher

    2020 - 2020

    Lab of Professor Andrew deMello: Cell Classification by Smartphone-based IFC As part of a lecture about Biomicrofluidic Engineering, I developed machine-learning-based cell classifiers using microfluidic, smartphone-based imaging flow cytometry measurements as input data.

  • Undergraduate Student Researcher (Bachelor Thesis)

    2020 - 2020

    Lab of Professor Thomas Carell: Development of caC- & hmC-Synthesis Routes I conceptualized, screened, and optimized CO-free synthesis routes toward the epigenetically relevant cytidine derivatives caC and hmC. I showed that carbon dioxide can act as an efficient carbon donor to aryl halides under mild conditions, atmospheric pressure, and without the use of metal catalysts.

2018 - 2019

  • Business Development Intern

    2019 - 2019

    Early-stage technology startup TWAICE, predictive battery analytics Focus of my work: customer archetype analysis, renewal of online marketing concept & web presence

  • Business Development Working Student

    2018 - 2019

    Focus of my work: market research to promote seed extension round, customer analysis, use case analysis, marketing Employee #8 (currently ~ 120)

2017 - 2017

  • Student Intern Research Department

    2017 - 2017

    One-week high school student internship in R&D department